The WACC of Anavex Life Sciences Corp (AVXL) is 9.2%.
| Range | Selected | |
| Cost of equity | 11.50% - 15.30% | 13.40% |
| Tax rate | 0.20% - 0.50% | 0.35% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 8.2% - 10.1% | 9.2% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.66 | 1.86 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 11.50% | 15.30% |
| Tax rate | 0.20% | 0.50% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 8.2% | 10.1% |
| Selected WACC | 9.2% | |